SI-BONE, Inc. (SIBN) NASDAQ
14.01
+0.14(+1.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.01
+0.14(+1.01%)
Currency In USD
| Previous Close | 13.87 |
| Open | 13.55 |
| Day High | 14.03 |
| Day Low | 13.41 |
| 52-Week High | 21.89 |
| 52-Week Low | 11.48 |
| Volume | 470,693 |
| Average Volume | 702,814 |
| Market Cap | 621.33M |
| PE | -35.92 |
| EPS | -0.39 |
| Moving Average 50 Days | 13.55 |
| Moving Average 200 Days | 15.76 |
| Change | 0.14 |
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026
GlobeNewswire Inc.
Feb 17, 2026 9:30 PM GMT
SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be part
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
GlobeNewswire Inc.
Feb 02, 2026 9:30 PM GMT
SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial resu
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
GlobeNewswire Inc.
Jan 12, 2026 2:00 PM GMT
Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20%SANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical